CalicoBiosystems

Description

CalicoBiosystems operates a patient-tumor–based oncology NAM (New Approach Methodologies) platform that applies multi-omics and AI-driven efficacy scoring to test drug candidates on intact tumors and generate predictive efficacy data for early drug development.

CalicoBiosystems is located in the Lake Geneva ecosystem.

Related

• SOPHiA GeneticsSOPHiA Genetics provides an AI-driven, cloud-powered SOPHiA DDM platform for analyzing genomics, radiomics, and multimodal health data to…
• WhiteLab GenomicsWhiteLab Genomics builds AI-driven computational platforms to design and optimize genomic medicines, producing in‑silico modules and…
• InSpheroInSphero provides human-tissue 3D in vitro cell-culture models, spheroid and organoid tools, and automation-compatible plates that support…
• Qubit PharmaceuticalsQubit Pharmaceuticals develops quantum- and AI-driven molecular modeling platforms and drug discovery tools used to design novel drug…
• DebiopharmDebiopharm develops and manufactures pharmaceutical drugs and invests in digital health, focusing on oncology and bacterial infections and…
• Orbis MedicinesOrbis Medicines applies its nGen AI-driven design-make-test platform to generate and synthesize large numbers of oral nCycle drug…
• Isomorphic LabsIsomorphic Labs uses machine learning to transform drug discovery by building predictive and generative AI models for designing molecules…
• Aukera Therapeutics GmbHAukera Therapeutics GmbH develops the first RAPTOR inhibitors, using an AI-driven drug discovery platform and mTOR biology expertise to…
• EndoVia TherapeuticsEndoVia Therapeutics builds a precision oncology platform that combines tumor profiling and AI-driven digital twin models to predict,…